Actively Recruiting
Effects of Acupuncture for Senile Pruritus
Led by Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-11-20
108
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Senile pruritus (SP), characterized by idiopathic itching in individuals aged 60 years and older without primary skin lesions, significantly impacts sleep and quality of life. Effective alternative treatments are needed. Acupuncture has been suggested as a potential intervention to alleviate itching; however, its role in managing SP remains uncertain. This study aims to evaluate the effects and safety of acupuncture for SP. This single-centre, parallel, two-arm, randomized, sham-controlled trial will enroll 108 patients diagnosed with SP in a 1:1 ratio to either the acupuncture or sham acupuncture group. Participants, outcome assessors, and the statistician will be blinded. Treatment will consist of 18 sessions over 6 weeks. The primary outcome is change from baseline in the Numerical Rating Scale (NRS) score for average itching severity at week 6, assessed weekly via weekly diary of pruritus assessment. Secondary outcomes include changes in NRS score for maximum itching severity, daily episodes of itching, itchy area of body surface, overall dry skin score (ODS), the Dermatology Life Quality Index (DLQI), the Pittsburgh Sleep Quality Index (PSQI), the Hospital Anxiety and Depression Scale (HADS), and Patient Global Impression of Change (PGIC). Adverse events will be monitored throughout the study period. The intention-to-treat (ITT) population will include participants who complete baseline assessments and receive at least one treatment session.
CONDITIONS
Official Title
Effects of Acupuncture for Senile Pruritus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants aged between 60 and 80 years
- Diagnosis of senile pruritus meeting study criteria
- Average itching severity score of 4 or higher on the Numerical Rating Scale in the past week
- Voluntary written informed consent provided
You will not qualify if you...
- Severe skin damage or infection
- Severe underlying diseases including cardiovascular, hepatobiliary, kidney, hematologic, autoimmune, infectious diseases, severe malnutrition, or malignancies
- Mental illness, cognitive dysfunction, or language disorders
- Acupuncture therapy for pruritus received within the past month
- History of drug abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100053
Actively Recruiting
Research Team
H
He Chen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here